SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-028694
Filing Date
2024-03-08
Accepted
2024-03-08 16:47:38
Documents
6
Effectiveness Date
2024-03-08

Document Format Files

Seq Description Document Type Size
1 S-8 janx_s-8_2024.htm S-8 105515
2 EX-5.1 janx-ex5_1.htm EX-5.1 17322
3 EX-23.1 janx-ex23_1.htm EX-23.1 2392
4 EX-FILING FEES janx-exfiling_fees.htm EX-FILING FEES 28295
5 GRAPHIC img151594875_0.jpg GRAPHIC 2126
6 GRAPHIC img151594875_1.jpg GRAPHIC 2126
  Complete submission text file 0000950170-24-028694.txt   160764
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277797 | Film No.: 24735178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)